Back to companies

Pacira BioSciences Inc: Overview

Pacira BioSciences Inc (Pacira), formerly Pacira Pharmaceuticals Inc, provides non-opioid pain management and regenerative health solutions. The company develops drugs based on its proprietary DepoFoam drug delivery technology. Its lead product candidate, Exparel (bupivacaine liposome injectable suspension) is an amide-type local anesthetic administered at the time of surgery to control pain and eliminate the use of opioids for acute postsurgical pain. Its other products include iovera, a non-opioid treatment intended to block pain, and relieve pain and symptoms related to osteoarthritis of the knee; among others. Its products are essentially used by hospitals, doctors and ambulatory surgery centers. The company sells products through co-promotion agreements and supply agreements with other pharmaceutical companies. The company has operations in the US and the UK. Pacira is headquartered in Tampa, Florida, the US.

Headquarters United States of America

Address 5401 West Kennedy Boulevard, Suite 890, Tampa, Florida, 33609


Telephone 1 813 5536680

No of Employees 697

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange PCRX (NASD)

Revenue (2020) $541.5M 26% (2020 vs 2019)

EPS XXX

Net Income (2020) XXX -71.2% (2020 vs 2019)

Market Cap* $2.7B

Net Profit Margin (2020) XXX -77.1% (2020 vs 2019)

* As of and is in US$

Access premium data and analytics for Pacira BioSciences Inc

130+

Clinical Trials

Determine Pacira BioSciences Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

50+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Pacira BioSciences Inc’s relevant decision makers and contact details.

20+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

18+

Pipeline Drugs

Identify which of Pacira BioSciences Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

5

Sales & Consensus Forecasts

Understand the current and future drug revenue for Pacira BioSciences Inc and assess market opportunity for new entrants with patient population 8-year forecasts.

5

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

4

Marketed Drugs

Understand Pacira BioSciences Inc’s commercialized product portfolio to stay one step ahead of the market.

80+

Install Base

Install Base provides a holistic and a granular view of the IT product/service deployments from leading vendors. Explore IT infrastructure categories, solution and product/service areas deployed by a prospect.

20+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

7

Medical Marketed Products

A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.

6

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Pacira BioSciences Inc’s likely spend across technology areas enabling you to understand the digital strategy.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Brands
Exparel - Surgical Infiltration and Interscalene Brachial Plexus Nerve Block Pacira
Iovera System - Total Knee Arthroplasty and Blocking of Pain EXPAREL
Zilretta - Management of OA knee pain DepoFoam
XXX XXX
XXX XXX
XXX XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2022 Contracts/Agreements In June, the company and the National Safety Council announced the launch of their partnership and the Connect2Prevent program.
2021 Acquisitions/Mergers/Takeovers In November, the company announced acquisition of Flexion Therapeutics, Inc, a biopharmaceutical company.
2021 Contracts/Agreements In August, the company's enhanced manufacturing process for EXPAREL secured the US FDA approval.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Pacira BioSciences Inc Napp Pharmaceuticals Ltd DURECT Corp AcelRx Pharmaceuticals Inc Akorn Inc
Headquarters United States of America United Kingdom United States of America United States of America United States of America
City Tampa Cambridge Cupertino Hayward Lake Forest
State/Province Florida England California California Illinois
No. of Employees 697 190 78 43 -
Entity Type Public Private Public Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
David Stack Chief Executive Officer; Chairman Executive Board 2013 71
Charles A. Reinhart III Chief Financial Officer Senior Management 2016 61
Kristen Williams Secretary; Chief Administrative Officer Senior Management 2014 48
Jonathan Slonin, MD Chief Clinical Officer Senior Management 2020 -
Charles Laranjeira Chief Technical Officer Senior Management 2018 56
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer